Table 1.

Patient and disease Characteristics of 450 men planned to undergo radiation therapy for localized prostate cancer, according to use of neoadjuvant ADT therapy.

		Treatment Group		p value
		No NADT (n=379)	NADT (n=71)
Age (years)	Mean (±sd)	66.4 (±7.7)	70.2 (±7.5)	<0.001
Race	White	83.4%	88.4%	0.444
	African American	15.2%	11.6%
	Other	1.3%	0%
Clinical Stage	T1	81.8%	57.8%	<0.001
	T2	18.2%	42.2%
Gleason Score	2–6	70.9%	18.3%	<0.001
	7	28.3%	46.5%
	8–10	0.8%	35.2%
PSA (ng/ml)	0–4	19.0%	14.1%	<0.001
	4–10	69.6%	50.7%
	>10	11.4%	35.2%
	Mean (sd)	6.2 (±3.4)	12.8 (±16.0)